Christopher Sweeney Named Executive Director, Intellectual Property
Acuitas Therapeutics, Inc.’s Chief Legal Officer & Vice President of Business Development, Miranda Lam, KC, recently announced that Christopher Sweeney has joined Acuitas Therapeutics (USA), Inc. as Executive Director of Intellectual Property (IP). In this senior role, Mr. Sweeney oversees the
Dr. Ghania Chikh: Expertise, Experience and Engagement with the Team!
The Acuitas team consists of brilliant, talented and experienced scientists and business professionals who are also interesting, engaging and fun-loving. This is just one of the many things that makes us unique at Acuitas. For Acuitas, the word “team” isn’t based
Welcome, Kyle Stephenson
Acuitas continues to grow (in size and geographic region), and we are thrilled to announce that Dr. Kyle Stephenson has joined the team as Director, Preclinical. While Kyle is based in the Greater Toronto Area (GTA), he will regularly be